Bayer bets on 'silver bullet' defense in Roundup litigation; experts see hurdles
Bayer AG plans to argue that a US$2 billion jury award and thousands of U.S. lawsuits claiming its glyphosate-based weed killer Roundup causes cancer should be tossed because a U.S. regulatory agency